Product Link
My Rx Pad
Email this list with product links
No Data Available
BlueStar®
By: Welldoc
.png)
Type 1 and type 2 diabetes capabilities within the larger Welldoc® digital health platform
BlueStar® is an FDA-cleared digital therapeutic designed to assist adults with type 1 and type 2 diabetes in managing their condition through personalized, real-time coaching and data-driven insights.
Personalized Coaching: Utilizes artificial intelligence to provide tailored feedback based on individual health data, promoting informed decision-making and encouraging healthy behaviors.
Integrated Device Connectivity: Supports integration with various devices, including continuous glucose monitors (CGMs) and insulin pens, to offer comprehensive management of diabetes.
Insulin Dosing Support: Features a bolus insulin dose calculator that considers factors like carbohydrate intake, CGM readings, activity levels, and insulin on board to recommend appropriate insulin doses.
Educational Resources: Provides access to diabetes-related educational content, empowering users with knowledge to better manage their condition.
The Welldoc chronic care platform includes first-in-class clinical, tech, and advanced AI expertise, as demonstrated by our 70+ clinical posters & publications, 41 patents, and 11 510(k) FDA clearances* for capabilities associated with type 1 and type 2 diabetes.
Additionally, Welldoc operates ahead of the curve of innovation in the digital health industry and continues to evolve and expand our offerings in line with market and consumer needs. This is possible through our deep understanding of the healthcare ecosystem, specialized expertise in digital health for chronic care and flexible, partnership-based model and tech. Our foresight into industry needs enables us to deliver a best-in-class digital health solution, while ensuring seamless integration into existing health ecosystems.
For full labeling information, visit welldoc.com
- Welldoc is committed to maintaining user privacy and takes security very seriously. It is paramount to our product capabilities and technical/security protections. We also work very closely with our customers to ensure that our processes/product is compliant with their pri
- Health Management
- Released
- Diabetes
- Patients
- Disease Management
- Mobile App
- FDA Cleared
- Endocrinology
- Software and Apps
Findings from a 2020 study focused on people with type 2 diabetes using a Welldoc-powered digital health app with a blood glucose meter (n=291):
1.83 average A1c reduction for those with A1c > 8*
Diabetes related ER visits decreased by 30% and all-cause visits by 55%*
Decrease in costs from baseline to follow-up by 55%*
Average of ~30 digital engagements/week reflecting impact to self-management*
Welldoc is also researching the power of real-time data devices like CGM in combination with digital health. In a recent study, we evaluated this impact on glucose control for individuals with Type 2 diabetes not treated with insulin. The time in range (TIR) and glucose management indicator (GMI) improved significantly across subpopulations. Most significantly, one cohort showed a TIR increase of 32% and a GMI improvement of 1.4. (n =91)**
* Snow K, Iyer Phd A, Shearer D, Peeples M. Interactive Digital Health: Engaging Healthy Behaviors & Clinical Outcomes.; 2020. Poster.
**Kumbara A, Iyer A, Leone K, Shomali M. Evaluating the Impact of a Combined Real-Tim
Welldoc currently has 11 510(k) FDA clearances* for type 1 and type 2 diabetes functionality within the platform.
*Welldoc Diabetes Rx/OTC is an FDA-cleared medical device (“BlueStar”), intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. For full labeling information, visit www.welldoc.c
- --
Regulatory Approval/ Qualifications
FDA Cleared
Write a Review
Related Products
